NCT00694356 2018-08-08Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)Merck Sharp & Dohme LLCPhase 1 Completed15 enrolled 13 charts
NCT00730379 2015-02-10A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)Merck Sharp & Dohme LLCPhase 1 Completed87 enrolled